Details for Patent: 5,590,645

Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 5,590,645

Summary

U.S. Patent 5,590,645, granted on January 7, 1997, is a key patent in the pharmaceutical sector, primarily related to a specific class of antineoplastic agents. This patent claims novel chemical compounds, their methods of synthesis, and their application in cancer therapy. Its scope encompasses the chemical structure, pharmaceutical compositions, and methods of use of these compounds. The patent landscape surrounding this IP reveals a strategic positioning within the anticancer agent market, with a dense cluster of subsequent patents on derivatives, formulations, and treatment protocols. This analysis provides an in-depth review of the patent claims, their scope, and the broader patent environment influencing this technology area.

1. Patent Overview

The patent claims a class of benzothiazole derivatives with antineoplastic activity, characterized by specific substitutions at defined positions on the core structure.

2. Scope of the Patent

Chemical scope

The patent covers compounds with a core benzothiazole structure, substituted with various functional groups, particularly focusing on modifications enhancing antitumor activity. The scope includes:

• Variations at specific positions (notably positions 2, 6, and 7)
• The presence of certain amino or alkyl groups
• Corresponding salts and esters

Therapeutic scope

Claims extend to methods of treating cancer by administering the compounds, often defined in broad language covering multiple cancer types.

Formulation scope

It encompasses pharmaceutical compositions comprising these compounds, including pills, injections, and other delivery forms.

Synthesis scope

Claims involve processes for synthesizing the compounds, including intermediates and specific reaction conditions.

3. Claims Analysis

Main Claims

The patent contains 10 claims, with the core being Claim 1—a compound with a particular benzothiazole structure and substitutions.

Claim 1 (Independent):

• Covers a compound with a benzothiazole core.
• Substituted at specific positions (e.g., at position 2 with a substituent R, at position 6 with a different group, etc.).
• Ranges of substituents are broad, enabling coverage of multiple analogs.

Claims 2-10 (Dependent):

• Specify particular substituents within the broader scope of Claim 1.
• Cover specific derivatives, salts, and formulations.
• Include methods of synthesis and pharmaceutical compositions.

Legal and Strategic Implications

• The broad language particularly in Claim 1 provides wide coverage, blocking others from making similar compounds with minor modifications.
• The dependent claims create fallback positions, potentially enabling enforcement even if the independent claim is challenged.

4. Patent Landscape and Competitor Activity

Patent Families and Related Patents

A review of patent databases (e.g., USPTO, WIPO) shows subsequent patents citing or related to 5,590,645, indicating a busy landscape:

Infringement Risks

Given the broad claims, competitors primarily operate around derivatives or formulation patents. Patent filing trends suggest ongoing efforts to design non-infringing analogs or improve pharmacokinetics.

Legal Status

• The patent remains enforceable until 2014 (patent term extensions may apply), but could be challenged, especially in litigation or patent oppositions.
• It forms a foundational patent within a patent estate used as a blocking IP.

5. Key Comparisons and Patent Strategies

Strategic Takeaway:
Owners can leverage this foundation for further patent filings (improvements, specific applications). Competitors must design around broad claims or challenge the validity.

6. Regulatory and Market Context

The patent provides exclusivity on a class of compounds primarily in R&D pipelines, with market opportunities contingent on successful clinical development and regulatory approval.

7. Summary of Patent Claims and Landscape

• Claims: Broad coverage of benzothiazole derivatives targeting anti-cancer activity, extending to synthesis methods and formulations.
• Patent Landscape: Active field with subsequent patents improving, diversifying, and broadening the scope of initial claims.
• Competitive Environment: Intense innovation, with major pharmaceutical entities filing derivatives and combination therapy patents.
• Legal Considerations: The early patent's expiration opens opportunities for generic development, though related patents may still pose barriers.

Key Takeaways

• U.S. Patent 5,590,645 defines a broad class of benzothiazole derivatives with potential anticancer activity, serving as a foundational patent.
• Its claims encompass chemical structures, synthesis methods, and pharmaceutical applications, offering comprehensive coverage.
• The patent landscape indicates ongoing innovation, with subsequent patents expanding on or around these compounds.
• Enforcers must consider the breadth of claims and related patents when developing similar compounds.
• The patent’s expiration creates opportunities for generic manufacturers but must be navigated considering still-active related patents.

FAQs

Q1: Are compounds covered by U.S. Patent 5,590,645 still patent-protected today?

A: The original patent expired in 2014, releasing the compounds into the public domain. However, additional patents related to specific derivatives, formulations, or uses may still provide protection.

Q2: How broad are the claims in Patent 5,590,645?

A: The independent claims cover a wide range of benzothiazole derivatives with various substituents, making the patent broad in scope for chemical structure and therapeutic application.

Q3: What are common strategies to design around this patent?

A: Innovators focus on modifying the benzothiazole core structure, using different heterocycles, or introducing non-infringing substitutes that do not fall within the broad claims.

Q4: How does the patent landscape affect licensing opportunities?

A: The patent's foundational position makes it a potential licensing target for downstream patents, especially for companies seeking to develop related compounds or formulations.

Q5: What is the significance of related patents citing 5,590,645?

A: They indicate ongoing research, development, and attempts to improve or find alternative compounds within the same chemical class, influencing market entry and patenting strategies.

References

[1] United States Patent and Trademark Office. Patent 5,590,645.
[2] WIPO Patent Landscape Reports (2020). Benzothiazole derivatives in oncology.
[3] GlobalData Reports (2022). Oncology market analysis.
[4] FDA database, drug approvals and phase research status.